Immunogenicity assessment groups based on the primary and booster vaccination schemes and timeframe from the second or booster dose. by Rima Moghnieh (679199)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Omicron BA.4/BA.5 variant wave. by Rima Moghnieh (679199)

Subjects:

LDHA expression is an independent prognostic factor for the overall survival of LUAD patients. by Siyu Yuan (7425719)

Subjects:

Humoral immune responses to SARS-CoV-2 spike protein following various primary vaccination schemes and booster doses with Sinopharm or Pfizer vaccines among COVID-19-naïve particip... by Rima Moghnieh (679199)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Alpha variant wave. by Rima Moghnieh (679199)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Omicron BA.1/BA.2 variant wave. by Rima Moghnieh (679199)

Subjects:

Knockdown of LDHA reduced cell viability and LDH activity in A549 and NCL-H1975 cells, enhancing chemotherapy sensitivity to LBP. by Siyu Yuan (7425719)

Subjects:

Oxamate reduces cell viability, LDHA expression, and LDH activity in A549 and NCL-H1975 cells, enhancing the cytotoxic effect of LBP. by Siyu Yuan (7425719)

Subjects:

High expression of LDHA in LUAD is associated with poor prognosis. by Siyu Yuan (7425719)

Subjects:

Fig 4 - by Rima Moghnieh (679199)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Delta variant wave. by Rima Moghnieh (679199)

Subjects:

Supplementing NAD+ counters the effects of Oxamate on metabolism and chemotherapy sensitivity. by Siyu Yuan (7425719)

Subjects:

Analysis of the correlation between LDHA expression and clinical characteristics. by Siyu Yuan (7425719)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the mixed Delta and Omicron variant wave. by Rima Moghnieh (679199)

Subjects:

COVID-19 in Lebanon: The daily number of COVID-19 cases throughout the waves of the pandemic in Lebanon and associated SARS-CoV-2 variants between January 2021 and September 2022. by Rima Moghnieh (679199)

Subjects:

Study profile. by Rima Moghnieh (679199)

Subjects:

Fig 3 - by Rima Moghnieh (679199)

Subjects:

Coefficients of mediation regression model. by Hongya Liu (487440)

“…<div><p>This study investigates the impact of low-carbon economic policies on Corporate Environmental Responsibility (CER) in Chinese A-share listed companies, with a particular focus on the role of financing constraints as a mediating factor. Despite a decrease in environmental pollution incidents in 2022, the economic and social impacts of such incidents remain significant, highlighting the need for stronger environmental governance. …”

Fig 4 - by Marjo K. Hytönen (8522271)

A working model for the RRSV Pns10-promoted RRSV infection in <i>N. lugens</i> through inducing NlNDUFS1-mediated mitochondrial apoptosis. by Lianshun Zheng (22086585)

“…This impairment of mitochondrial complex I activity results in a significant decrease of ATP production and an increase of mitochondrial ROS production, which causes mitochondrial apoptosis to facilitate RRSV infection in <i><i>N. lugens</i></i>.…”